Results 151 to 160 of about 39,159 (175)

Choosing between dual and three-drug antiretroviral therapy in aging and comorbid people with HIV: a narrative review. [PDF]

Front Reprod Health
Cossu MV, Matone M, Iannone V, Fusetti C, Colombo V, Gori A, Ridolfo AL, Gervasoni C.   +7 more
europepmc   +1 more source

HIV Resistance to Dolutegravir Varies With Coadministered Agents. [PDF]

Clin Infect Dis
Beck IA, Boyce CL, Bishop MD, Oldroyd AR, du Toit L, Saimen A, Ramarope KM, Hitchcock S, du Plessis NM, Mbogo L, Chohan BH, Maheria P, Oyaro P, Knowles K, Zhang Z, Brummel SS, Drain PK, Smith RA, Gottlieb GS, Abuogi L, Patel RC, Farquhar C, Wiznia A, Ruel TD, Rossouw TM, Hawes SE, Frenkel LM.   +26 more
europepmc   +1 more source

Clinical and biological risk factors influencing infant HIV status: a case study of Kisenyi Health Center IV, Kampala, Uganda. [PDF]

BMC Infect Dis
Bagonza FX, Asiimwe JB, Wamono F, Nsimbe D.   +3 more
europepmc   +1 more source

Efficacy of dolutegravir/lamivudine in adults with HIV-1 and isolated reactive hepatitis B core antibody: Insights from Phase 3/3b study results. [PDF]

HIV Med
Fox D, Slim J, Overton ET, Doblado-Maldonado A, Jeffery P, Grove RA, Advani SD, Borsi R, Parry CM, Underwood M, Jones B.   +10 more
europepmc   +1 more source

Are screening periods in ART-naive trials justified in the era of rapid ART? [PDF]

Lancet HIV
Short WR, Koenig S, Tebas P, Gandhi M.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A Randomized Study Comparing Lamivudine Monotherapy After a Short Course of Hepatitis B Immune Globulin (HBIg) and Lamivudine With Long-Term Lamivudine Plus HBIg in the Prevention of Hepatitis B Virus Recurrence After Liver Transplantation

Journal of Hepatology, 2003
Maria Buti, Fernando Casafont, Martin Prieto   +2 more
exaly  

Lamivudine Resistance Inimmunocompetent Chronic Hepatitis B

Journal of Hepatology, 1997
Hubert G.M. Niesters, Solko W Schalm, S W Schalm   +2 more
exaly  

Hepatitis-B-Virus Resistance to Lamivudine Given for Recurrent Infection After Orthotopic Liver Transplantation

Lancet, The, 1997
Rajender Reddy, Nathaniel A Brown, Lennox J Jeffers   +2 more
exaly  

20-Fold Increase in Risk of Lamivudine Resistance in Hepatitis B Virus Subtype Adw

Lancet, The, 2001
Matthias Schröter, Heinz-Hubert Feucht, Bernhard Zöllner   +2 more
exaly  

Safety and Efficacy of Adefovir Dipivoxil in Patients Co-Infected With HIV-1 and Lamivudine-Resistant Hepatitis B Virus: An Open-Label Pilot Study

Lancet, The, 2001
Vincent Thibault, Thierry Poynard, Yves Benhamou   +2 more
exaly